InvaGen to continue to hold shares in Avenue Therapeutics: Cipla
Synopsis : In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business…
Synopsis : In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business…
Summary : The company will invest up ₹6 crore for the 33% stake in the target firm Cipla on Wednesday announced that…
Synopsis- Alembic said it has acquired preferred stock in RIGImmune amounting to a 19.97% post-money stake in the first closing of the…